Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis

Live biotherapeutic products constitute an emerging therapeutic approach to prevent or treat inflammatory bowel diseases. Lactobacillus acidophilus is a constituent of the human microbiota with probiotic potential, that is illustrated by improvement of intestinal inflammation and antimicrobial activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hrdý, Jiří, Couturier-Maillard, Aurélie, Boutillier, Denise, Lapadatescu, Carmen, Blanc, Philippe, Procházka, Jan, Pot, Bruno, Ryffel, Bernhard, Grangette, Corinne, Chamaillard, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585059/
https://www.ncbi.nlm.nih.gov/pubmed/36266398
http://dx.doi.org/10.1038/s41598-022-21643-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585059/
https://www.ncbi.nlm.nih.gov/pubmed/36266398
http://dx.doi.org/10.1038/s41598-022-21643-0

Ejemplares similares